Menu Menu Menu Login Login Log in Search Search Search

Oxford PharmaScience Group Plc (OXP) Ordinary 0.1p

Sell:1.20p Buy:1.30p 0 Change: No change  
Market closed Prices as at close on 22 November 2017 Prices delayed by at least 15 minutes | Switch to live prices |
Shareholder Meeting

Oxford PharmaScience Group Plc Ordinary 0.1p

Type:
Shareholder Meeting
Shareholder action required:
Yes
Status:
Client deadline 22 Nov 2017
Details (last updated 14 Nov 2017)

Following a strategic review of the Group’s operations, the Board of Oxford Pharmascience Group plc recently announced proposals to demerge certain assets to Oxford Pharmascience Group plc and change its name to Abaco Capital plc.

 

The Demerger will become effective on 20 December 2017 with Shareholders receiving 1 Oxford Pharmascience Limited Share for every 25 Shares held at the close of business on 1 December 2017. The new Shares are expected to be received from 29 December 2017.

 

These proposals are subject to Shareholder approval at a General Meeting to be held on 27 November 2017. If you wish to register a vote for or against the proposals you must do so before our noon 22 November 2017 deadline.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:1.20p
Buy:1.30p
Change: No change  
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed Prices as at close on 22 November 2017 Prices delayed by at least 15 minutes | Switch to live prices |
Shareholder Meeting

Oxford PharmaScience Group Plc Ordinary 0.1p

Type:
Shareholder Meeting
Shareholder action required:
Yes
Status:
Client deadline 22 Nov 2017
Details (last updated 14 Nov 2017)

Following a strategic review of the Group’s operations, the Board of Oxford Pharmascience Group plc recently announced proposals to demerge certain assets to Oxford Pharmascience Group plc and change its name to Abaco Capital plc.

 

The Demerger will become effective on 20 December 2017 with Shareholders receiving 1 Oxford Pharmascience Limited Share for every 25 Shares held at the close of business on 1 December 2017. The new Shares are expected to be received from 29 December 2017.

 

These proposals are subject to Shareholder approval at a General Meeting to be held on 27 November 2017. If you wish to register a vote for or against the proposals you must do so before our noon 22 November 2017 deadline.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:1.20p
Buy:1.30p
Change: No change  
Market closed Prices as at close on 22 November 2017 Prices delayed by at least 15 minutes | Switch to live prices |
Shareholder Meeting

Oxford PharmaScience Group Plc Ordinary 0.1p

Type:
Shareholder Meeting
Shareholder action required:
Yes
Status:
Client deadline 22 Nov 2017
Details (last updated 14 Nov 2017)

Following a strategic review of the Group’s operations, the Board of Oxford Pharmascience Group plc recently announced proposals to demerge certain assets to Oxford Pharmascience Group plc and change its name to Abaco Capital plc.

 

The Demerger will become effective on 20 December 2017 with Shareholders receiving 1 Oxford Pharmascience Limited Share for every 25 Shares held at the close of business on 1 December 2017. The new Shares are expected to be received from 29 December 2017.

 

These proposals are subject to Shareholder approval at a General Meeting to be held on 27 November 2017. If you wish to register a vote for or against the proposals you must do so before our noon 22 November 2017 deadline.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
1.25p
Trade high:
1.25p
Year high:
3.65p
Market capitalisation
Market cap.
:
£15.07 million
Previous close:
1.25p
Trade low:
1.23p
Year low:
1.10p
P/E ratio:
n/a
Previous:
0.08p (6.84%)
Previous:
0.08p
Volume:
332,700
Dividend yield:
n/a
EMS:
75,000
Data delayed by at least 15 minutes.

Performance

Not available for this stock.

Fundamental data

Year ending: 31/12/2016 31/12/2015
Revenue (£m) 0.80 0.75
Profit before tax (£m) (1.90) (3.88)
Adjusted EPS (p): (0.11) (0.28)
P/E ratio n/a n/a
PEG n/a n/a
EPS growth (%) n/a n/a

Values are quoted in the stock's local currency: British pound

All fundamental data

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Open an easy to manage, low cost dealing account in less than 5 minutes

Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.

More about the Fund & Share Account

Important Documents

There are no documents available for this stock.

Broker forecasts

Broker recommendations for this stock are not available.

Time / date Time Buy / sell Type Volume Price Value
×

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.